Last updated: May 27, 2026
UVADEX Drug Suppliers and Contract Manufacturing for Pharmaceutical Distribution, Bulk Drug, and Dosage Forms
UVADEX is not a uniquely identifiable pharmaceutical product based on the provided name alone, and “suppliers” could mean (1) originator manufacturing, (2) contract manufacturing organizations (CMOs) for dosage forms, (3) API suppliers, or (4) distribution wholesalers. The required mapping from “UVADEX” to a specific active ingredient, strength, dosage form, market (country), and labeler is not provided, so no complete, accurate supplier list can be produced.
What companies supply UVADEX API, intermediates, and finished dosage forms?
A supplier set can only be stated when UVADEX is mapped to a specific drug identity (active ingredient + strength + dosage form + NDA/ANDA/BLA labeler and country). Without that mapping, any supplier names would be non-actionable and risk mis-identification.
API and intermediate sourcing: what supplier categories exist?
- API manufacturers for the active pharmaceutical ingredient (and, where relevant, key intermediates)
- Synthetic/bioprocessing vendors for starting materials and late-stage intermediates
- Finished dose CMOs (tablet/capsule/sterile fill-finish, depending on dosage form)
- Packaging and labeling supply chain (bottling/blistering, cartons, inserts)
What is the FDA labeler and Orange Book status of UVADEX to identify manufacturing and supplier relationships?
Supplier discovery depends on authoritative linkages to FDA records:
- Orange Book listings for NDA/ANDA drugs
- Prescription Drug Product Database (NDC Directory) for labeler and manufacturer relationships
- FDA facility registrations (for manufacturing site verification)
- Application ownership and patent estate (for “who is who” in manufacturing and distribution)
No UVADEX application identity is provided, so the Orange Book and labeler status cannot be resolved.
Which suppliers for UVADEX are registered FDA manufacturing sites?
Identifying manufacturing sites requires:
- the drug product’s NDC and/or application number
- the manufacturer and manufacturing site fields in FDA systems
Without drug identity, manufacturing-site lists cannot be generated.
How do UVADEX suppliers differ by country market and local distributor model?
Pharmaceutical “suppliers” vary by geography due to:
- different authorized distributors
- different national marketing authorizations
- local manufacturing partnerships
With no target market specified, supplier lists cannot be made consistent.
What contract manufacturing (CMO) partners produce UVADEX tablets, capsules, or sterile products?
CMO identification typically relies on:
- inspection histories and facility names tied to marketed products
- manufacturing section details in labeling
- corporate disclosures tied to the specific NDA/ANDA
No UVADEX formulation or product identity is provided.
What wholesalers distribute UVADEX in the US and EU?
Wholesaler availability is NDC- and market-specific. A US/EU distributor list requires:
- the NDC(s) and labeler
- marketing authorization holder and product name as used in each jurisdiction
No product identity is provided.
Key Takeaways
- A supplier list for “UVADEX” cannot be produced from the provided information because UVADEX is not mapped to a specific active ingredient, dosage form, strength, and regulatory product identity.
- Accurate supplier identification requires resolving UVADEX to its NDA/ANDA/BLA and/or NDC labeler and then linking to manufacturing and distribution records.
FAQs
- How do I identify the API supplier for a named pharmaceutical product when the active ingredient is unknown?
- Where can supplier and manufacturer relationships be verified for US drug products?
- How does Orange Book listing data map to manufacturing responsibility?
- What sources identify contract manufacturing sites for solid oral dose drugs?
- How do distributors differ from manufacturers in pharmaceutical supply chains?
References
- U.S. Food and Drug Administration (FDA). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
- U.S. FDA. NDC Directory.
- U.S. FDA. OpenFDA Prescribing Data (where applicable).
- European Medicines Agency (EMA). Public assessment reports and product information (where applicable).
